Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Price : 2.93 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 2.83 | 2.99 | 2.83 | 2.93 | 603897.0 |
| Aug 21, 2026 | 2.80 | 2.875 | 2.794 | 2.87 | 202716.0 |
| Aug 20, 2026 | 2.80 | 2.87 | 2.75 | 2.77 | 323759.0 |
| Aug 19, 2026 | 2.93 | 2.93 | 2.79 | 2.85 | 536560.0 |
| Aug 18, 2026 | 2.82 | 2.91 | 2.76 | 2.91 | 593190.0 |
| Aug 17, 2026 | 2.89 | 2.896 | 2.730 | 2.82 | 838777.0 |
| Aug 14, 2026 | 2.92 | 3.02 | 2.71 | 2.93 | 1.032M |
| Aug 13, 2026 | 2.76 | 3.055 | 2.70 | 2.98 | 1.394M |
| Aug 12, 2026 | 2.61 | 2.78 | 2.57 | 2.75 | 1.008M |
| Aug 11, 2026 | 2.74 | 2.74 | 2.60 | 2.61 | 617236.0 |
| Aug 10, 2026 | 2.66 | 2.790 | 2.63 | 2.75 | 542785.0 |
| Aug 07, 2026 | 2.77 | 2.85 | 2.65 | 2.67 | 579991.0 |
| Aug 06, 2026 | 2.79 | 2.85 | 2.70 | 2.77 | 651385.0 |
| Aug 05, 2026 | 2.78 | 2.875 | 2.75 | 2.79 | 702322.0 |
| Aug 04, 2026 | 2.70 | 2.80 | 2.662 | 2.72 | 992373.0 |
| Aug 03, 2026 | 2.97 | 2.97 | 2.62 | 2.76 | 2.314M |
| Jul 31, 2026 | 3.28 | 3.28 | 3.080 | 3.13 | 643005.0 |
| Jul 30, 2026 | 3.36 | 3.45 | 3.27 | 3.29 | 464021.0 |
| Jul 29, 2026 | 3.38 | 3.46 | 3.32 | 3.35 | 324762.0 |
| Jul 28, 2026 | 3.26 | 3.39 | 3.15 | 3.39 | 404400.0 |
| Jul 27, 2026 | 3.36 | 3.505 | 3.225 | 3.27 | 413364.0 |
| Jul 24, 2026 | 3.465 | 3.49 | 3.27 | 3.34 | 414539.0 |
| Jul 23, 2026 | 3.53 | 3.59 | 3.385 | 3.43 | 445374.0 |
| Jul 22, 2026 | 3.55 | 3.65 | 3.49 | 3.55 | 604714.0 |
| Jul 21, 2026 | 3.39 | 3.600 | 3.34 | 3.53 | 557290.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.25 |
| Ironwood Pharmaceuticals, Inc. | 4.13 |
| Kura Oncology, Inc. | 12.40 |
| Spero Therapeutics, Inc. | 1.215 |
| Cue Biopharma, Inc. | 23.18 |
Price Related Metrics
| PE Ratio | 1.103 |
| PS Ratio | 1.441 |
| Price to Book Value | 0.5946 |
| Price to Free Cash Flow | 0.8201 |
| Earnings Yield | 90.67% |
| Market Cap | 97.60M |
| Normalized PE Ratio | 1.197 |